Literature DB >> 33692202

HIV-1 uncoating occurs via a series of rapid biomechanical changes in the core related to individual stages of reverse transcription.

Sanela Rankovic1, Akshay Deshpande1, Shimon Harel1, Christopher Aiken2, Itay Rousso1.   

Abstract

The HIV core consists of the viral genome and associated proteins encased by a cone-shaped protein shell termed the capsid. Successful infection requires reverse transcription of the viral genome and disassembly of the capsid shell within a cell in a process known as uncoating. The integrity of the viral capsid is critical for reverse transcription, yet the viral capsid must be breached to release the nascent viral DNA prior to integration. We employed atomic force microscopy to study the stiffness changes in HIV-1 cores during reverse transcription in vitro in reactions containing the capsid-stabilizing host metabolite IP6 Cores exhibited a series of stiffness spikes, with up to three spikes typically occurring between 10-30, 40-80, and 120-160 minutes after initiation of reverse transcription. Addition of the reverse transcriptase (RT) inhibitor efavirenz eliminated the appearance of these spikes and the subsequent disassembly of the capsid, thus establishing that both result from reverse transcription. Using timed addition of efavirenz, and analysis of an RNAseH-defective RT mutant, we established that the first stiffness spike requires minus-strand strong stop DNA synthesis, with subsequent spikes requiring later stages of reverse transcription. Additional rapid AFM imaging experiments revealed repeated morphological changes in cores that were temporally correlated with the observed stiffness spikes. Our study reveals discrete mechanical changes in the viral core that are likely related to specific stages of reverse transcription. These reverse-transcription-induced changes in the capsid progressively remodel the viral core to prime it for temporally accurate uncoating in target cells.ImportanceFor successful infection, the HIV-1 genome, which is enclosed inside a capsid shell, must be reverse transcribed into double-stranded DNA and released from the capsid (in a process known as uncoating) before it can be integrated into the target cell genome. The mechanism of HIV-1 uncoating is a pivotal question of long standing. Using atomic force microscopy to analyze individual HIV-1 cores during reverse transcription, we observe a reproducible pattern of stiffness spikes. These spikes were shown to be associated with distinct stages of the reverse transcription reaction. Our findings suggest that these reverse-transcription-induced alterations gradually prepared the core for uncoating at the right time and location in target cells.
Copyright © 2021 American Society for Microbiology.

Entities:  

Year:  2021        PMID: 33692202      PMCID: PMC8139671          DOI: 10.1128/JVI.00166-21

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  33 in total

1.  Human immunodeficiency virus type 1 N-terminal capsid mutants that exhibit aberrant core morphology and are blocked in initiation of reverse transcription in infected cells.

Authors:  S Tang; T Murakami; B E Agresta; S Campbell; E O Freed; J G Levin
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

2.  Reverse Transcription Mechanically Initiates HIV-1 Capsid Disassembly.

Authors:  Sanela Rankovic; Janani Varadarajan; Ruben Ramalho; Christopher Aiken; Itay Rousso
Journal:  J Virol       Date:  2017-05-26       Impact factor: 5.103

3.  Biochemical and structural analysis of isolated mature cores of human immunodeficiency virus type 1.

Authors:  R Welker; H Hohenberg; U Tessmer; C Huckhagel; H G Kräusslich
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

4.  Endogenous reverse transcription of human immunodeficiency virus type 1 in physiological microenviroments: an important stage for viral infection of nondividing cells.

Authors:  H Zhang; G Dornadula; R J Pomerantz
Journal:  J Virol       Date:  1996-05       Impact factor: 5.103

5.  HIV capsid is a tractable target for small molecule therapeutic intervention.

Authors:  Wade S Blair; Chris Pickford; Stephen L Irving; David G Brown; Marie Anderson; Richard Bazin; Joan Cao; Giuseppe Ciaramella; Jason Isaacson; Lynn Jackson; Rachael Hunt; Anne Kjerrstrom; James A Nieman; Amy K Patick; Manos Perros; Andrew D Scott; Kevin Whitby; Hua Wu; Scott L Butler
Journal:  PLoS Pathog       Date:  2010-12-09       Impact factor: 6.823

6.  Permeability of the HIV-1 capsid to metabolites modulates viral DNA synthesis.

Authors:  Chaoyi Xu; Douglas K Fischer; Sanela Rankovic; Wen Li; Robert A Dick; Brent Runge; Roman Zadorozhnyi; Jinwoo Ahn; Christopher Aiken; Tatyana Polenova; Alan N Engelman; Zandrea Ambrose; Itay Rousso; Juan R Perilla
Journal:  PLoS Biol       Date:  2020-12-17       Impact factor: 8.029

7.  The Host Cell Metabolite Inositol Hexakisphosphate Promotes Efficient Endogenous HIV-1 Reverse Transcription by Stabilizing the Viral Capsid.

Authors:  Jordan Jennings; Jiong Shi; Janani Varadarajan; Parker J Jamieson; Christopher Aiken
Journal:  mBio       Date:  2020-12-01       Impact factor: 7.867

8.  Analysis of the mechanical properties of wild type and hyperstable mutants of the HIV-1 capsid.

Authors:  Ruben Ramalho; Sanela Rankovic; Jing Zhou; Christopher Aiken; Itay Rousso
Journal:  Retrovirology       Date:  2016-03-15       Impact factor: 4.602

Review 9.  IP6 Regulation of HIV Capsid Assembly, Stability, and Uncoating.

Authors:  Robert A Dick; Donna L Mallery; Volker M Vogt; Leo C James
Journal:  Viruses       Date:  2018-11-15       Impact factor: 5.818

10.  Nuclear pore blockade reveals that HIV-1 completes reverse transcription and uncoating in the nucleus.

Authors:  Adarsh Dharan; Niklas Bachmann; Sarah Talley; Virginia Zwikelmaier; Edward M Campbell
Journal:  Nat Microbiol       Date:  2020-06-01       Impact factor: 30.964

View more
  11 in total

Review 1.  Insights into HIV uncoating from single-particle imaging techniques.

Authors:  Margaret J Zhang; Jeffrey H Stear; David A Jacques; Till Böcking
Journal:  Biophys Rev       Date:  2022-01-11

2.  Molecular Biology and Diversification of Human Retroviruses.

Authors:  Morgan E Meissner; Nathaniel Talledge; Louis M Mansky
Journal:  Front Virol       Date:  2022-06-02

Review 3.  Teaching old dogmas new tricks: recent insights into the nuclear import of HIV-1.

Authors:  Adarsh Dharan; Edward M Campbell
Journal:  Curr Opin Virol       Date:  2022-02-01       Impact factor: 7.121

Review 4.  Disassembling the Nature of Capsid: Biochemical, Genetic, and Imaging Approaches to Assess HIV-1 Capsid Functions.

Authors:  Zachary Ingram; Douglas K Fischer; Zandrea Ambrose
Journal:  Viruses       Date:  2021-11-07       Impact factor: 5.048

Review 5.  Inositol Phosphates and Retroviral Assembly: A Cellular Perspective.

Authors:  Clifton L Ricaña; Robert A Dick
Journal:  Viruses       Date:  2021-12-15       Impact factor: 5.048

Review 6.  The Role of Capsid in HIV-1 Nuclear Entry.

Authors:  Anabel Guedán; Eve R Caroe; Genevieve C R Barr; Kate N Bishop
Journal:  Viruses       Date:  2021-07-22       Impact factor: 5.048

7.  HIV-1 Nucleocapsid Protein Binds Double-Stranded DNA in Multiple Modes to Regulate Compaction and Capsid Uncoating.

Authors:  Helena Gien; Michael Morse; Micah J McCauley; Jonathan P Kitzrow; Karin Musier-Forsyth; Robert J Gorelick; Ioulia Rouzina; Mark C Williams
Journal:  Viruses       Date:  2022-01-25       Impact factor: 5.048

Review 8.  The Role of Capsid in the Early Steps of HIV-1 Infection: New Insights into the Core of the Matter.

Authors:  Nawal AlBurtamani; Alwin Paul; Ariberto Fassati
Journal:  Viruses       Date:  2021-06-17       Impact factor: 5.048

Review 9.  The HIV-1 capsid and reverse transcription.

Authors:  Christopher Aiken; Itay Rousso
Journal:  Retrovirology       Date:  2021-09-25       Impact factor: 4.602

Review 10.  Applications of Atomic Force Microscopy in HIV-1 Research.

Authors:  Itay Rousso; Akshay Deshpande
Journal:  Viruses       Date:  2022-03-21       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.